Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice

Annals of the New York Academy of Sciences

Volumn 1085, Issue , 2006, Pages 74-81

  Yoshimura, Koichi ^a   Aoki, Hiroki ^a   Ikeda, Yasuhiro ^a   Furutani, Akira ^a   Hamano, Kimikazu ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdominal aortic aneurysm; c Jun N terminal kinase; Extracellular matrix; Matrix metalloproteinase; Pharmacological therapy; Regression

Indexed keywords

ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APOLIPOPROTEIN E; CALCIUM CHLORIDE; COLLAGEN FIBER; ELASTIN; GELATINASE B; PROTEIN LYSINE 6 OXIDASE; STRESS ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AORTA WALL; BIOSYNTHESIS; BLOOD VESSEL DIAMETER; CONFERENCE PAPER; ECHOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; EXTRACELLULAR MATRIX; GENE TARGETING; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; REMISSION; TISSUE REPAIR; ANIMAL; ARTICLE; DISEASE COURSE; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; MOUSE; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; PROTEIN KINASE INHIBITORS;

EID: 34447617524     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1383.031     Document Type: Conference Paper

References (16)

1. PYO, R. et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649.
2. LONGO, G.M. et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110: 625-632.
3. THOMPSON, R.W., P.J. GERAGHTY & J.K. LEE. 2002. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr. Probl. Surg. 39: 110-230.
4. BAXTER, B.T. 2004. Could medical intervention work for aortic aneurysms? Am. J. Surg. 188: 628-632.
5. PETRINEC, D. et al. 1996. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg. 23: 336-346.
6. HUFFMAN, M.D. et al. 2000. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128: 429-438.
7. PRALL, A.K. et al. 2002. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J. Vasc. Surg. 35: 923-929.
8. MOSORIN, M. et al. 2001. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J. Vasc. Surg. 34: 606-610.
9. BAXTER, B.T. et al. 2002. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J. Vasc. Surg. 36: 1-12.
10. BUTH, J. & P. HARRIS. 2005. Endovascular Treatment of Aortic Aneurysms. In Vascular Surgery, R.B. Rutherford, ED.: 1452-1475. Elsevier. Philadelphia.
11. YOSHIMURA, K. et al. 2005. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 11: 1330-1338.
12. MANNING, A.M. & R.J. DAVIS. 2003. Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2: 554-565.
13. YOSHIMURA, K. et al. Identification of c-Jun N-terminal kinase as a therapeutic target for abdominal aortic aneurysm. Ann. N. Y. Acad. Sci. This volume.
14. BENNETT, B.L. et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681-13686.
15. KAGAN, H.M. & W. LI. 2003. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88: 660-672.
16. DAUGHERTY, A., M.W. MANNING & L.A. CASSIS. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105: 1605-1612.